ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 453053 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
-15.4%
Revenue CAGR (3yr)
6.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $21M | $23M | $15M | -32.7% | -15.4% |
| Operating Expenses | $20M | $20M | $14M | -28.1% | -15.2% |
| Operating Margin | 6.4% | 12.1% | 6.1% | -49.8% | -2.6% |
| Net Income | $1M | $3M | $1M | -66.2% | -17.6% |
| Licensed Beds | 60 | 60 | 60 | +0.0% | +0.0% |
| Total Patient Days | 14,444 | 15,381 | 9,983 | -35.1% | -16.9% |
| Medicare Day % | 76% | 76% | 71% | -6.7% | -3.5% |
| Medicaid Day % | 0% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -28.4% ($21M → $15M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-15.4%
This Hospital
+7.6%
State Avg
Latest Margin
6.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $12M | 5.9% |
| FY2024 (proj) | $9M | 5.7% |
| FY2025 (proj) | $6M | 5.6% |